← AlphaSignal

WST

★★☆☆☆ Passmistral

West Pharmaceutical Services, Inc.

Healthcare · sector percentile 69

세션 움직임

$353.32

+$0.24+0.07%

거래량 0.84× 평균

59/100 quant · tgt $404.73

ADV$ 194.5M

세션 2026-08-24 · 스냅샷 — 실시간 호가 아님

직전 스캔 대비

2026-08-21 → 2026-08-25

점수-1.3가격−$0.45 · -0.13%

참고용이며 매수/매도 신호가 아닙니다. 스캔 이력과 캐시된 뉴스·공시로 구성됩니다.

스냅샷 시세

세션 2026-08-24 · 스캔 2026-08-25

시세 상세 보기
종가/스캔가
$353.32
전일 종가
$353.08
푸시 최신가
—
세션 시가
$350.48
직전 세션 범위
$348.95 – $354.48
52주 범위
$325.06 – $360.29
세션 거래량
472,559
평균 거래량 (20일)
560,643
시가총액
$24.87B
PER (TTM)
45.24
Forward PER
35.46
배당 수익률
0.25%
1년 목표가 추정
$404.73
다음 실적
—

Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes.

시장 브리핑

선별된 요약입니다 — 매매 신호가 아닙니다. 헤드라인·링크는 제공된 그대로 표시됩니다.

이 종목의 최근 헤드라인이 없습니다.

Price Chart

Daily prices from cache

Loading price history…

AI Analysis

  • Bull Thesis — West Pharmaceutical Services benefits from resilient healthcare demand, strong FCF margins (8.4%), and consistent earnings surprises (16.8% beat rate) in drug delivery solutions.
  • Risks — High valuation (trailing P/E 45x) and debt-to-equity (10.6x) limit margin for error in growth slowdown.
  • Target Upside — 14.5% upside to $405 target from current $353, supported by analyst mean price and 5-year revenue growth (13.8% YoY).

Score History

2026-08-1359.0 pts · 2026-08-25

8 days of scans. Daily batch adds the next weekday automatically while the API is running.

  • DatePriceChgScoreRating
  • 2026-08-25$353.32−$0.4559.0Pass
  • 2026-08-21$353.77+$0.9860.3Pass
  • 2026-08-20$352.79+$6.2060.5Pass
  • 2026-08-19$346.59−$0.0259.0Pass
  • 2026-08-18$346.61−$2.8160.0Pass
  • 2026-08-17$349.42+$3.2660.5Pass
  • 2026-08-14$346.16−$0.7059.6Pass
  • 2026-08-13$346.87—59.6Pass

Quant Breakdown

Revenue Growth
5.5
EPS Growth
7.2
ROE
9.2
PER Relative
1.1
Debt / Equity
8.0
FCF Margin
4.5
Analyst Upside
4.8
Insider / Sector
2.0
Momentum 3M
8.7
Earn. Surprise
8.0

Short volume (FINRA)

Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.

as of 2026-08-21 · finra_cnms
Short / total
44.9%
vs 20d (z)
-0.83
Short vol
104,321
Status
ok

Squeeze pressure score

full

21/100

Short leg
8
Call leg
48
Activity
1.6
Call vol share
71.5%
PCR (vol)
0.40
Call OI share
0.0%
ATM IV
0.0%

FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.

공시 점수 (Disclosure)

캐시된 SEC 공시 기반 News / Insider / Earnings 규칙 다리 — 참고용이며, beat/miss나 매수 신호가 아닙니다.

점수 창에 최근 SEC 공시·실적 일정 입력이 아직 없습니다.

Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.

실적 서프라이즈 (퀀트 맥락)

최근 퀀트 스캔에 캐시된 Yahoo/공개 펀더멘털 수치입니다 — 공시 이벤트 점수에 합산되지 않으며 매수 신호가 아닙니다. 최신 발표보다 늦을 수 있습니다.

최근 보고 서프라이즈 +0.2%

Filings & events

Recent SEC disclosures and earnings dates — context only, not a trade signal.

as of 2026-08-12·sec_edgar·CIK 0000105770
Next earnings
2026-10-22yahoo_calendar
Last earnings
—

SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.